-
Mashup Score: 33
Treatments that aid inflammation resolution, immune tolerance, and epithelial repair may improve outcomes beyond high-dose corticosteroids and other b…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Two experts explore the essentials of Graft vs Host Disease (GvHD), understanding its symptoms, diagnosis, and distinguishing characteristics between acute and chronic forms.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Clinical Evolution of Treatment in Chronic Graft vs. Host Disease - 2 month(s) ago
Dr. Zeiser discusses the dynamic clinical evolution of Graft vs Host Disease (GvHD) in a concise overview, gaining insights into its progression and changing manifestations over time.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1First line Treatment and Challenges in Chronic GvHD - 3 month(s) ago
Explore the primary treatment options for chronic Graft vs Host Disease (cGvHD) and delve into the challenges associated with prolonged steroid use, focusing on dosing strategies and adverse event management.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8
Treatments that aid inflammation resolution, immune tolerance, and epithelial repair may improve outcomes beyond high-dose corticosteroids and other broad immunosuppressants for life-threatening acute graft-versus-host disease (aGVHD). We studied the addition of urinary-derived human chorionic gonad …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 20Titans of Transplant: Dr. Stephanie Lee by ASTCT Talks - 4 month(s) ago
In the next installment of ASTCT’s Titans of Transplant series, Dr. Stephanie Lee is interviewed by Dr. Jennifer Saultz. Dr. Lee shares her journey from Seattle to becoming a professor at Fred Hutch Cancer Center. The conversation highlights early motivations, challenges faced during fellowship, and the influence of her father’s advice to always strive for the best. They also discuss Dr. Lee’s groundbreaking work in chronic graft-versus-host-disease research, collaborative efforts, FDA-approved treatments, and the evolving landscape in the field. The Titans of Transplant series seeks to recognize, celebrate and chronicle the physicians, researchers, pharmacists, nurses, social workers and more who were on the frontlines of the early days of transplant. About Stephanie Lee, MD, MPH Dr. Stephanie Lee (@StephanieLeeMD) is a hematologist and physician scientist who is Professor and Associate Director at the Fred Hutchinson Cancer Research Center. Dr. Lee works to improve the lives of blood
Source: podcasters.spotify.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1FDA Grants Orphan Designation to Drug Candidate for Oral GVHD | Blood Cancers Today - 4 month(s) ago
GVHD affects approximately 30,000 Americans, according to Dr. Michael Chancellor, Chief Medical Officer at Lipella.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1NICE Shares Positive Opinion on Belumosudil for Chronic GVHD - 4 month(s) ago
Belumosudil is the first therapy within England and Wales available for the treatment of patients 12 years and older who have previously undergone a minimum of 2 lines of systemic treatment.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Study Evaluates Effect of Belumosudil on Pulmonary Function, Corticosteroid Doses in Chronic GVHD - 4 month(s) ago
Home > GVHD > Study Evaluates Effect of Belumosudil on Pulmonary Function, Corticosteroid Doses in Chronic GVHD Patients receiving belumosudil for chronic graft-versus-host-disease (GVHD) may tolerate lower doses of prednisone, according to a recent study. Rebecca Sabates, MD, of the University of Kansas Medical Center, and colleagues conducted the study because chronic GVHD is a “major complication” of allogeneic hematopoietic stem cell transplantation (HSCT). Chronic GVHD can affect multiple organ
Source: www.cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0alloHSCT Yields Benefits in R/R AML Regardless of Leukemia Burden - 5 month(s) ago
Those with chronic graft-versus-host-disease who have received allogeneic hematopoietic stem cell transplant may experience enhanced graft-versus-leukemia effects, thus producing a lower relapse rate in acute myeloid leukemia.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
Remember that crazy idea to give pregnancy hormones as supportive care for life-threatening #GVHD? This guy was from the beginning — first entertained the research idea with me 17 years ago. Meet my OB and personal hero, @creedondj 👇❤️ https://t.co/ekvgKTRmVy https://t.co/gI9aJTwOIv